BSE · COLINZ

Colinz Laboratories ltd.

Sector: Healthcare · ISIN: INE923C01011

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.

Market cap rank

#4,136

of 5,088 stocks

🏆 New peak

▲ 211W

Peak #4,136 · 30 Sep 2026

Colinz Laboratories ltd., a microcap Healthcare business, is seeing revenue slip, commands a premium earnings multiple, and posts a modest return on equity. Ownership as of Jun 2026.

Market Cap

19.32 Cr

P/E Ratio

37.59

P/B Ratio

1.92

ROE

5.12%

ROCE

7.20%

Dividend Yield

—

52W High

—

52W Low

—

Quarterly financials

Metric	Q1 2026-27	Q4 2025-26	Q3 2025-26	Q2 2025-26
Revenue	1.24 Cr	1.75 Cr	1.43 Cr	1.39 Cr
Net Profit	2.40 Cr	17.12 L	8.36 L	14.05 L
EPS	9.53	—	0.33	0.56
Operating Profit	14.52 L	5.19 L	13.74 L	4.03 L

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter

50.60%

Public

49.40%

PUBLIC BREAKDOWN

Individuals

46.77%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

No corporate actions on record for this stock.

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs